StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
NASDAQ ATHX opened at $0.01 on Friday. Athersys has a one year low of $0.01 and a one year high of $1.99. The firm has a market capitalization of $833,206.50, a P/E ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
Featured Articles
- Five stocks we like better than Athersys
- What Investors Need to Know About Upcoming IPOs
- Disney’s Magic Strategy: Reinventing the House of Mouse
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Conference Calls and Individual Investors
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
